Myovant Sciences Ltd Stock News

Myovant Sciences (NYSE:MYOV) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday, Zacks.com report

Connor Clark & Lunn Investment Management Ltd. bought a new stake in Myovant Sciences Ltd (NYSE:MYOV) in the fourth quarter, according to the company in its most recent 13F filing with the Securities

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo acquired 140,000 shares of the firm’s stock in a transaction dated Tuesday, March 31st. The stock was purchased at an av

Tables of the top insider purchases and sales filed with the SEC on 4/1/20, based on dollar value. Dollar values often do not equate with significance when it c

Tables of the top insider purchases and sales filed with the SEC on 3/30/20, based on dollar value. Dollar values often do not equate with significance when it

Captrust Financial Advisors bought a new stake in Myovant Sciences Ltd (NYSE:MYOV) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institu

Myovant Sciences Ltd (NYSE: MYOV) shares are trading higher on Tuesday, after the company, along with Gedeon Richter, announced they have entered into an exclusive license...

SG Blocks (NASDAQ:SGBX) +100% on Q4 results.EyeGate Pharmaceuticals (NASDAQ:EYEG) +51% on positive dry eye data.Kiniksa Pharmaceuticals (NASDAQ:KNSA) +39% as mavrilimumab shows treatment response i

Myovant Sciences (NYSE:MYOV) has entered into an exclusive license agreement with Gedeon Richter Plc., a Central Eastern Europe-based pharmaceutical company, where the latter will commercialize rel

Myovant Sciences, Gedeon Richter enter license agreement for relugolix MYOV

PRAGUE — Central European stock marketsregained some ground on Tuesday after Chinese data offering somerelief for global investors, but remained on course for theirbiggest monthly drop since …

Central European stock markets regained some ground on Tuesday after Chinese data offering some relief for global investors, but remained on course for their biggest monthly drop since the 2008 financ

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 140,000 shares of the company’s stock in a transaction on Friday, March 27th. The stock was bought at an avera

Richter Gedeon Vegyeszeti Gyar Nyrt :

Myovant Sciences Ltd: